OLDER AGE AND ELEVATED BLOOD-PRESSURE ARE RISK-FACTORS FOR INTRACEREBRAL HEMORRHAGE AFTER THROMBOLYSIS

被引:53
作者
ANDERSON, JL
KARAGOUNIS, L
ALLEN, A
BRADFORD, MJ
MENLOVE, RL
PRYOR, TA
机构
[1] LDS Hospital, University of Utah, Salt Lake City, UT
关键词
D O I
10.1016/0002-9149(91)90738-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intracerebral hemorrhage is an important concern after thrombolytic therapy for acute myocardial infarction, but risk factors are controversial. Accordingly, we assessed risk factors in 107 treated patients of whom 4 had intracerebral hemorrhage. Intracerebral hemorrhage occurred at a mean of 25 hours (range 3.5 to 48) after therapy and was fatal in 2 patients. Significant differences were found between patients with and without intracerebral hemorrhage for age (77 +/- 7 vs 62 +/- 11 years, p less-than-or-equal-to 0.01), and initial (161 +/- 23 vs 135 +/- 23 mm Hg, p less-than-or-equal-to 0.03) and maximal (171 +/- 30 vs 146 +/- 20, p less-than-or-equal-to 0.02) systolic blood pressures. Initial and maximal diastolic blood pressures also tended to be higher (101 +/- 25 vs 86 +/- 16, p less-than-or-equal-to 0.07; 104 +/- 24 vs 90 +/- 13, p less-than-or-equal-to 0.06). Differences did not achieve significance for comparisons of gender, height, weight, site of infarction, time to therapy, specific thrombolytic agent used, concomitant therapy, interventions and partial thromboplastin time. It is concluded that age (greater-than-or-equal-to 70 years) and elevated blood pressure (greater-than-or-equal-to 150/95 mm Hg) are important risk factors for intracerebral hemorrhage. The overall balance of benefit and risk of thrombolysis should continue to be assessed by large mortality trials.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 17 条
  • [1] THE WESTERN WASHINGTON MYOCARDIAL-INFARCTION REGISTRY AND EMERGENCY DEPARTMENT TISSUE PLASMINOGEN-ACTIVATOR TREATMENT TRIAL
    ALTHOUSE, R
    MAYNARD, C
    CERQUEIRA, MD
    OLSUFKA, M
    RITCHIE, JL
    KENNEDY, JW
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (19) : 1298 - 1303
  • [2] [Anonymous], 1988, LANCET, V2, P349
  • [3] [Anonymous], 1986, LANCET, V1, P397
  • [4] [Anonymous], 1989, NEW ENGL J MED, V320, P618
  • [5] INTRACEREBRAL HEMORRHAGE COMPLICATING INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR TREATMENT
    CARLSON, SE
    ALDRICH, MS
    GREENBERG, HS
    TOPOL, EJ
    [J]. ARCHIVES OF NEUROLOGY, 1988, 45 (10) : 1070 - 1073
  • [6] INTRACEREBRAL HEMORRHAGE, CEREBRAL INFARCTION, AND SUBDURAL-HEMATOMA AFTER ACUTE MYOCARDIAL-INFARCTION AND THROMBOLYTIC THERAPY IN THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION STUDY - THROMBOLYSIS IN MYOCARDIAL-INFARCTION, PHASE-II, PILOT AND CLINICAL-TRIAL
    GORE, JM
    SLOAN, M
    PRICE, TR
    RANDALL, AMY
    BOVILL, E
    COLLEN, D
    FORMAN, S
    KNATTERUD, GL
    SOPKO, G
    TERRIN, ML
    [J]. CIRCULATION, 1991, 83 (02) : 448 - 459
  • [7] ANTICOAGULANT-RELATED INTRACEREBRAL HEMORRHAGE
    KASE, CS
    ROBINSON, RK
    STEIN, RW
    DEWITT, LD
    HIER, DB
    HARP, DL
    WILLIAMS, JP
    CAPLAN, LR
    MOHR, JP
    [J]. NEUROLOGY, 1985, 35 (07) : 943 - 948
  • [8] INTRACRANIAL HEMORRHAGE AFTER USE OF TISSUE PLASMINOGEN-ACTIVATOR FOR CORONARY THROMBOLYSIS
    KASE, CS
    ONEAL, AM
    FISHER, M
    GIRGIS, GN
    ORDIA, JI
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (01) : 17 - 21
  • [9] ADMINISTRATION OF THROMBOLYTIC THERAPY IN THE COMMUNITY-HOSPITAL - ESTABLISHED PRINCIPLES AND UNRESOLVED ISSUES
    MARK, DB
    HLATKY, MA
    OCONNOR, CM
    PRYOR, DB
    WALL, TC
    HONAN, MB
    PHILLIPS, HR
    CALIFF, RM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (06) : A32 - A43
  • [10] STROKE AND ACUTE MYOCARDIAL-INFARCTION IN THE THROMBOLYTIC ERA - CLINICAL CORRELATES AND LONG-TERM PROGNOSIS
    OCONNOR, CM
    CALIFF, RM
    MASSEY, EW
    MARK, DB
    KEREIAKES, DJ
    CANDELA, RJ
    ABBOTTSMITH, C
    GEORGE, B
    STACK, RS
    ARONSON, L
    MANTELL, S
    TOPOL, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (03) : 533 - 540